US Stock MarketDetailed Quotes
OMIC Singular Genomics
- 21.370
- -0.050-0.23%
Close Nov 25 16:00 ET
53.68MMarket Cap-616P/E (TTM)
21.750High21.000Low24.03KVolume21.505Open21.420Pre Close513.64KTurnover1.52%Turnover RatioLossP/E (Static)2.51MShares23.41052wk High0.44P/B33.82MFloat Cap5.34052wk Low--Dividend TTM1.58MShs Float1001.100Historical High--Div YieldTTM3.50%Amplitude5.340Historical Low21.376Avg Price1Lot Size
Singular Genomics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -17.69%-19.79M | 9.80%-18.04M | -32.17%-23.7M | 15.44%-73.65M | 5.10%-18.9M | 22.83%-16.81M | 21.74%-20M | 9.60%-17.93M | -68.46%-87.09M | -26.87%-19.92M |
| Net income from continuing operations | 24.89%-16.8M | 16.91%-21.25M | -5.89%-25.02M | -4.34%-94.82M | -10.18%-23.25M | 6.01%-22.36M | -6.65%-25.58M | -7.39%-23.63M | 7.99%-90.88M | -6.79%-21.1M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.36%60K | ---- |
| Depreciation and amortization | -9.57%1.69M | -5.42%1.78M | -5.23%1.72M | 19.74%7.22M | -3.89%1.65M | 12.18%1.87M | 22.05%1.88M | 64.88%1.82M | 432.39%6.03M | 372.80%1.72M |
| Other non cash items | -182.49%-1.55M | 21.21%40K | 2.63%39K | 2,329.70%4.01M | 5,179.49%2.06M | 3,897.87%1.88M | -21.43%33K | 2.70%38K | -99.53%165K | 8.33%39K |
| Change In working capital | -4,844.55%-5.22M | 32.35%-548K | -358.33%-2.59M | 86.65%-2.25M | 58.78%-981K | 103.08%110K | 88.67%-810K | 84.81%-564K | -477.71%-16.82M | -1,157.78%-2.38M |
| -Change in receivables | 170.03%257K | -1,583.33%-303K | -52.39%428K | 138.12%348K | 81.82%-166K | ---367K | ---18K | --899K | ---913K | ---913K |
| -Change in inventory | 97.73%-32K | 25.62%-270K | -258.84%-1.32M | 73.77%-3.54M | -948.69%-2.6M | 68.60%-1.41M | 93.94%-363K | 125.05%831K | ---13.49M | --306K |
| -Change in prepaid assets | -220.18%-780K | 78.36%-296K | 60.14%1.65M | -16.06%507K | -81.72%195K | 10.75%649K | 49.28%-1.37M | -37.44%1.03M | 108.82%604K | 229.18%1.07M |
| -Change in payables and accrued expense | -17.94%837K | -43.20%718K | 15.30%-2.73M | 267.22%1.82M | 200.25%2.77M | 74.66%1.02M | -12.16%1.26M | -811.86%-3.23M | -123.99%-1.09M | -363.67%-2.76M |
| -Change in other current assets | -99.01%11K | --0 | --72K | 100.22%2K | -5,866.67%-1.04M | 10,000.00%1.11M | -137.37%-71K | --0 | 14.89%-892K | 113.95%18K |
| -Change in other current liabilities | -515.87%-5.51M | -56.30%-397K | -603.09%-682K | -33.27%-1.39M | -40.00%-140K | -229.04%-895K | -179.12%-254K | 83.19%-97K | -332.14%-1.04M | -174.63%-100K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -17.69%-19.79M | 9.80%-18.04M | -32.17%-23.7M | 15.44%-73.65M | 5.10%-18.9M | 22.83%-16.81M | 21.74%-20M | 9.60%-17.93M | -68.46%-87.09M | -26.87%-19.92M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 271.21%42.29M | 168.30%23.96M | -56.71%31.58M | 134.90%13.81M | 280.70%651K | 35.19%-24.7M | -250.65%-35.09M | 769.84%72.95M | 69.76%-39.57M | 100.73%171K |
| Net PPE purchase and sale | 93.64%-7K | 99.67%-1K | 84.57%-25K | 83.89%-970K | 78.44%-392K | 90.24%-110K | 85.69%-306K | 82.75%-162K | -23.81%-6.02M | -2.71%-1.82M |
| Net investment purchase and sale | 272.00%42.3M | 168.90%23.97M | -56.77%31.6M | 144.05%14.78M | -47.56%1.04M | 33.51%-24.59M | -342.04%-34.78M | 683.99%73.11M | 73.38%-33.54M | 109.23%1.99M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 271.21%42.29M | 168.30%23.96M | -56.71%31.58M | 134.90%13.81M | 280.70%651K | 35.19%-24.7M | -250.65%-35.09M | 769.84%72.95M | 69.76%-39.57M | 100.73%171K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -87.06%80K | 0 | -22.75%696K | -90.40%72K | 0 | 511.88%618K | -73.91%6K | -99.76%901K | -7.41%750K |
| Net common stock issuance | ---- | ---- | --0 | 95.78%-19K | -117.14%-6K | ---- | ---- | 36.36%-7K | -100.19%-450K | 192.11%35K |
| Proceeds from stock option exercised by employees | --0 | -86.91%80K | --0 | -47.08%715K | -89.09%78K | -97.46%13K | 578.89%611K | -61.76%13K | -69.06%1.35M | -15.68%715K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -87.06%80K | --0 | -22.75%696K | -90.40%72K | --0 | 511.88%618K | -73.91%6K | -99.76%901K | -7.41%750K |
| Net cash flow | ||||||||||
| Beginning cash position | -59.86%30.72M | -81.14%24.71M | -77.84%16.83M | -62.34%75.98M | -63.13%35.01M | -50.58%76.53M | -31.17%130.99M | -62.34%75.98M | 1,557.65%201.74M | -60.42%94.97M |
| Current changes in cash | 154.21%22.51M | 111.03%6.01M | -85.68%7.88M | 52.97%-59.14M | 4.30%-18.18M | 30.66%-41.52M | -53.61%-54.47M | 581.34%55.02M | -166.34%-125.76M | 50.29%-19M |
| End cash Position | 52.01%53.22M | -59.86%30.72M | -81.14%24.71M | -77.84%16.83M | -77.84%16.83M | -63.13%35.01M | -50.58%76.53M | -31.17%130.99M | -62.34%75.98M | -62.34%75.98M |
| Free cash flow | -16.97%-19.8M | 11.16%-18.04M | -31.12%-23.73M | 19.87%-74.62M | 11.23%-19.29M | 26.14%-16.92M | 26.67%-20.3M | 12.91%-18.1M | -64.62%-93.12M | -24.42%-21.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data